Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Human Pilot Study on Positive Electrostatic Charge Effects in Solid Tumors of the Late-Stage Metastatic Patients Publisher



Zandi A1, 2 ; Shojaeian F1, 3 ; Abbasvandi F4, 5 ; Faranoush M6, 7 ; Anbiaee R8 ; Hoseinpour P1, 9 ; Gilani A1 ; Saghafi M1 ; Zandi A1, 2 ; Hoseinyazdi M11 ; Davari Z1 ; Miraghaie SH1 ; Tayebi M4 ; Taheri MS12 Show All Authors
Authors
  1. Zandi A1, 2
  2. Shojaeian F1, 3
  3. Abbasvandi F4, 5
  4. Faranoush M6, 7
  5. Anbiaee R8
  6. Hoseinpour P1, 9
  7. Gilani A1
  8. Saghafi M1
  9. Zandi A1, 2
  10. Hoseinyazdi M11
  11. Davari Z1
  12. Miraghaie SH1
  13. Tayebi M4
  14. Taheri MS12
  15. Ardestani SMS13
  16. Sheikhi Mobarakeh Z14
  17. Nikshoar MR15
  18. Enjavi MH1, 2
  19. Kordehlachin Y1
  20. Mousavikiasary SMS1
  21. Mamdouh A1
  22. Akbari ME5
  23. Yunesian M16, 17
  24. Abdolahad M1, 2, 18, 19
Show Affiliations
Authors Affiliations
  1. 1. Nano Electronic Centre of Excellence, Nanobioelectronic Devices Laboratory, Cancer Electronics Research Group, School of Electrical and Computer Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran
  2. 2. Nano Electronic Centre of Excellence, Nanoelectronics and Thin Film Laboratory, School of Electrical and Computer Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran
  3. 3. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of ATMP, Breast Cancer Research Centre, Motamed Cancer Institute, ACECR, Tehran, Iran
  5. 5. Cancer Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Pediatric Growth and Development Research Centre, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
  7. 7. Cardio-Oncology Research Centre, Rajaie Cardiovascular Medical and Research Centre, Iran University of Medical Sciences, Tehran, Iran
  8. 8. Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  9. 9. SEPAS Pathology Laboratory, Tehran, Iran
  10. 10. Department of Otolaryngology, Head and Neck Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  11. 11. Medical Imaging Research Centre, Shiraz University of Medical Sciences, Shiraz, Iran
  12. 12. Department of Radiology, Shohada Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  13. 13. Department of Psychiatry, Behavioural Sciences Research Centre, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  14. 14. Department of Quality of Life, Breast Cancer Research Centre, Motamed Cancer Institute, ACECR, Tehran, Iran
  15. 15. Department of Gastroenterology Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  16. 16. Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Department of Research Methodology and Data Analysis, Institute for Environmental Research, Tehran University of Medical Sciences, Tehran, Iran
  18. 18. Imam-Khomeini Hospital, Tehran University of Medical Sciences, Cancer Institute, Tehran, Iran
  19. 19. UT&TUMS Cancer Electrotechnique Research Centre, YAS Hospital, Tehran, Iran

Source: Frontiers in Medicine Published:2023


Abstract

Background: Correlative interactions between electrical charges and cancer cells involve important unknown factors in cancer diagnosis and treatment. We previously reported the intrinsic suppressive effects of pure positive electrostatic charges (PEC) on the proliferation and metabolism of invasive cancer cells without any effect on normal cells in cell lines and animal models. The proposed mechanism was the suppression of pro-caspases 3 and 9 with an increase in Bax/Bcl2 ratio in exposed malignant cells and perturbation induced in the KRAS pathway of malignant cells by electrostatic charges due to the phosphate molecule electrostatic charge as the trigger of the pathway. This study aimed to examine PECs as a complementary treatment for patients with different types of solid metastatic tumors, who showed resistance to chemotherapy and radiotherapy. Methods: In this study, solid metastatic tumors of the end-stage patients (n = 41) with various types of cancers were locally exposed to PEC for at least one course of 12 days. The patient’s signs and symptoms, the changes in their tumor size, and serum markers were followed up from 30 days before positive electrostatic charge treating (PECT) until 6 months after the study. Results: Entirely, 36 patients completed the related follow-ups. Significant reduction in tumor sizes and cancer-associated enzymes as well as improvement in cancer-related signs and symptoms and patients’ lifestyles, without any side effects on other tissues or metabolisms of the body, were observed in more than 80% of the candidates. Conclusion: PECT induced significant cancer remission in combination with other therapies. Therefore, this non-ionizing radiation would be a beneficial complementary therapy, with no observable side effects of ionizing radiotherapy, such as post-radiation inflammation. Copyright © 2023 Zandi, Shojaeian, Abbasvandi, Faranoush, Anbiaee, Hoseinpour, Gilani, Saghafi, Zandi, Hoseinyazdi, Davari, Miraghaie, Tayebi, Taheri, Ardestani, Sheikhi Mobarakeh, Nikshoar, Enjavi, Kordehlachin, Mousavi-kiasary, Mamdouh, Akbari, Yunesian and Abdolahad.